Market Cap

BELLUS Health Inc. Market Capitalization:

C$2.47 Billion

CAD as of June 1, 2023

US$1.86 Billion

business BELLUS Health Inc. Company Profile

BELLUS Health Inc. Main Stock Listing

TSX: BLU

Market Capitalization History of BELLUS Health Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of BELLUS Health Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 C$1.35 B 35.84%
Jan. 1, 2022 C$990.8 M 88.46%
Jan. 1, 2021 C$525.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

BELLUS Health Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

BELLUS Health Inc. has the following listings and related stock indices.


Stock: TSX: BLU

Stock: NASDAQ: BLU

Stock: FSX: BHN0

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.